Eli Lilly Earnings Miss, Covid-19 Treatment Fails In Trials

Eli Lilly Earnings Miss, Covid-19 Treatment Fails In Trials
  • Oops!
    Something went wrong.
    Please try again later.

Eli Lilly early Tuesday posted third-quarter earnings and sales that missed Wall Street expectations and said that one of its Covid-19 treatments failed in clinical trials; LLY stock fell.